The cellular immunology of multiple sclerosis

Journal of Leukocyte Biology

Volumn 65, Issue 4, 1999, Pages 444-452

  Al Omaishi, Jinan ^a   Bashir, Rifaat ^a   Gendelman, Howard E ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Cytokines; Myelin; Oligodendrocyte

Indexed keywords

AZATHIOPRINE; BETA1A INTERFERON; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GAMMA INTERFERON; GLATIRAMER; INTERFERON BETA SERINE; INTERLEUKIN 1; INTERLEUKIN 2; MATRIX METALLOPROTEINASE; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; B LYMPHOCYTE; BLOOD BRAIN BARRIER; CELLULAR IMMUNITY; CLINICAL FEATURE; COMPLEMENT SYSTEM; CYTOKINE PRODUCTION; DEMYELINATION; DRUG EFFICACY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LEUKOCYTE MIGRATION; MACROPHAGE; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; OLIGODENDROGLIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0032948960     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.65.4.444     Document Type: Article

References (68)

1. Adams, R. D., Maurice, V. (1993) Multiple sclerosis and allied demyelinative diseases. In Principles of Neurology (W. J. Lamsback and M. Navrozov, eds.) McGraw-Hill, 776-781.
2. McFarland, H. F. (1993) Twin studies and MS. Ann. Neurol. 33, 722-723.
3. Paty, D. W., Ebers, G. C. (1998) Clinical features. In Multiple Sclerosis (D. Paty and G. Ebers eds.) Philadelphia: Davis, 139.
4. Sorensen, T. L., and Ransohoff, R. M. (1998) Etiology and pathogenesis of multiple sclerosis. Semin. Neurol. 18, 287-294.
5. Wuchenpfenning, K., Strominger, J. (1995) Molecular mimicry in T cell mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 365, 642-644.
6. Brocke, S., Gaur, A., Piercy, C., et al. (1993) Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature 365, 642-644.
7. Raine, C. S. (1991) Demyelinating disease. In Textbook of Neuropathology, 2nd ed. (R. L. Davis and D. M. Robertson, eds.) Baltimore, MD: Williams & Wilkins, 535-620.
8. Selmaj, K. W, Raine, C. S. (1998) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23, 339-346.
9. Calabresi, P. A, Tranquil, L. R., McFarland, H. F., Cowan, E. P (1998) Cytokine gene expression in cells derived from CSF of multiple sclerosis patients. J. Neuroimmunol. 89, 198-205.
10. Brosnan, C. F., Canella, B., Battistini, L. Raine, C. S. (1995) Cytokine localization in multiple sclerosis lesions. Neurology 45 (Suppl. 6), 516-521.
11. Martenson, R. E. (1992) Myelin Biology and Chemistry. Boca Raton, FL: CRC Press, 49-53.
12. Calding, N. J, Compston, D. A. S. (1991) Oligodendrocyte macrophage interactions in vitro triggered by specific antibodies. Immunol. 72, 127-132.
13. Smith, M. E, DeJong, L. A. (1987) Antibodies to myelin constituents, a possible factor in reduction of cell mediated demyelination. Neurochem. Res. 12, 167-172.
14. Ozawa, K., Suchanek, G., Breitschoff, H., Bruck, W., Budka, H., Jellinger, K., and Lassmann, H. (1994) Pattern of oligodendroglia pathology in multiple sclerosis. Brain 117, 1311-1322.
15. Zajicek, J., Wing, M., Skepper, J., and Compston, A. (1995) Human oligodendrocytes are not sensitive to complement. A study of CD59 expression in human CNS. Lab. Invest. 73, 128-138.
16. Noronha, A. B. C., Richman, D. P., Arnason, B. G. W. (1980) Detection of in vivo stimulated CSF lymphocyte by flow cytometry in patient with multiple sclerosis. N. Engl. J. Med. 303, 713-717.
17. Reunanen, M. I. (1982) Spontaneous proliferation of CSF mononuclear cells in multiple sclerosis. J. Neuroimmunol. 3, 275-283.
18. Hohlfeld, R., Londei, M., Massacesi, L., and Salveth, M. (1995) T-cell autoimmunology in multiple sclerosis. Trends Immunol. Today 16, 259-261.
19. Hafler, D. A., Saadeh, M. G., Kuchroo, V. K., Milford, E., and Steinman, L. (1996) TCR usage in human and experimenta demyelinating disease. Trends Immunol. Today 17, 152.
20. Raine, C. S. (1991) Multiple sclerosis. A pivotal role for the T cell in lesion development. Neuropathol. Appl. Neurobiol. 17, 265-274.
21. Raine, C. S. (1994) The Dale E. McFarlin Memorial Lecture: The Immunology of MS lesion. Ann. Neurol. 36, 61-72.
22. Zamnill, S. S, Steinman, L. (1990) The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8, 579-621.
23. + Ab, effect on T cell response to MBP and EAE. J. Immunol. 141, 464-468.
24. Hauser, S. L., Bhan, A. K., Gilles, F., Kemp, M., Kerr, C., Weiner, H. L. (1986) Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann. Neurol. 19, 578-588.
25. Traugott, V. (1985) Characterization and distribution of lymphocyte subpopulations in MS plaques vs autoimmune demyelinating lesions. Semin. Immunopathol. 8, 71-95.
26. + myelin peptide-specific T cell importance of IFN-inducible protein 10, IP-10. J. Immunol. 160, 444-448.
27. + T cells make discrete contributions to demyelinating and neurologic disease in a viral model of multiple sclerosis. J. Virol. 72, 7320-7329.
28. Murray, P. D., McGovern, D. B., Lin, X., Njenga, M. K., Liebowitze, J., Pease, L. R., Rodriguez, M. (1998) Perforin dependent neurologic injury in a viral model of MS. J. Neurosci. 18, 7306-7314.
29. Wucherpfennig, K. W., Newcombe, J. A., Li, H., Keddy, C., Cuzner, M. L., Hafler, D. A. (1992) T-Cell receptor Vα-Vβ repertoire and cytokine gene expression in active MS lesions. J. Exp. Med. 175, 993-1002.
30. Kaufmann, S. H. E. (1906) γδ and other unconventional T lymphocytes: what do they see and what do they do. Proc. Natl. Acad. Sci. USA 93, 2272-2279.
31. Prineas, J. W., Wright, R. G. (1978) Macrophage, lymphocyte and plasma cells in the perivascular compartment in chronic MS. Lab. Invest. 38, 409-421.
32. Traugott, V., Reinherz, E. L, Raine, C. S. (1983) Multiple sclerosis: distribution of T cell subsets and Ia-positive macrophage in lesions of different ages. J. Neuroimmunol. 4, 201-221.
33. Brosnan, C. F., Bornstein, M. B., Bloom, B. R. (1981) The effect of macrophage depletion the clinical and pathologic expression of EAE. J. Immunol. 126, 614-620.
34. Diemel, L. T., Copelman, C. A., Cuzner, M. L. (1998) Macrophage in CNS: friend or foe? Neurochem. Res. 23, 341-347.
35. Hickey, W. F., Kimura, H. (1988) Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239, 290-292.
36. Oehrmann, J., Banati, R. B., Kreutzberg, G. W. (1993) Microglia in the immune surveillance of the brain: human microglia constitutively express HLA-Dr molecules. J. Neuroimmunol. 48, 189-198.
37. Matsumoto, Y., Ohmori, K., Fujiwara, M. (1981) Microglial and astroglial reactions to inflammatory lesions of EAE. J. Immunol. 126, 614-620.
38. Rajan, A. G., Gaoy, L., Rain, C. S., Brosnan, C. F. (1996) A pathogenic role for T cells in relapsing remitting experimental allergic encephalomyelitis in the SJL mouse. J. Immunol. 157, 941-947.
39. Smith, M. E., Smera, F. P., Eng, L. F. (1983) Immunology to chemical staining for glial fibrillary acidic protein and the metabolism of cytoskeletal protein in experimental allergic encephalomyelitis. Brain Res. 264, 241-253.
40. Lee, S. C., Dickson, D. W., Liu, W., Brosnan, C.F. (1993) Induction of nitric oxide synthase activity in human astrocytes by IL-1β and IFN-γ. J. Neuroimmunol. 46, 19-24.
41. Cross, A. H., Misko, T. P., Lin, R. F., Hickey, W. F., Trotter, J. L., Tilton, R. G. (1994) Aminoguanidine, an inhibitor of inducible nitric oxide synthetase ameliorate EAE in SJL mice. J. Clin. Invest. 93, 2684-2690.
42. Meinl, E., Aloisi, F., Ertl, B., Weber, F., deWard, M. R., Wekerle, H., Hohlfed, R. (1994) Immunomodulatory effect of human astrocyte on T cells. Brain 117, 1323-1332.
43. Mussini, J. M., Mawn, J., Delasneire, N., Schuller, E., Escourolle, R. (1980) Intracytoplasmic immunoglobulin-binding lymphoid cells (IgGLC) of the cerebrospinal fluid in multiple sclerosis and other neurological disorder. Ann. Immunol. 313C, 55-67.
44. Antel, J. P., Oger, J. J. F., Medof, M. E., Aranason, B. G. W. (1980) Role of cerebrospinal fluid complement on binding of immune complexes to cells. Neurology 3, 447-448.
45. Kabat, E. A., Moore, D. H., Landow, H. (1942) An electrophoretic study of the protein component in the cerebrospinal fluid and their relation to serum protein. J. Clin. Invest. 21, 571-577.
46. + ligand interaction in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA 19, 2499-2504.
47. Willenborg, D. O., Prowse, S. J. (1983) Immunoglobulin-deficient rats fail to develop experimental allergic encephalomylitis. J. Neuroimmunol. 5, 99-109.
48. Fabry, Z., Cedric, S. Raine, C. S. Hart, M. (1994) Nervous tissue as an immune compartment the dialect of the immune response in the CNS review. Immunol. Today. 15, 218-224.
49. Selmaj, K., Raine, C., Cannella, B., et al. (1997) Identification of lymphtoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 37, 949-954.
50. Williams, K. C, Ulvestad, E., Hickey, W. F. (1994) Immunology of multiple sclerosis. Clin. Neurosci. 2, 229-245.
51. Liu, J., Marino, M., Wong, G., et al. (1998) TNF is a potent antiinflammatory cytokine in autoimmune mediated demyelination. Nature Med. 4, 78-83.
52. Cures, J. H. A. J., Meis, J. F. G. M., et al. (1997) A primer on cytokines: sources, receptor effects and inducers. Clin. Microbial. Rev. 10, 742-780.
53. Jacobs, C. A., Baker, P. E., Roux, E. R., et al. (1991) Experimental autoimmune encephalomyelitis is exacerbated by IL-1 and suppressed by soluble IL-1 receptors. J. Immunol. 146, 2983-2989.
54. Antel, J. P., and Becker, B. (1997) Cytokine pathways in neurological disease. Immune regulatory pathways in autoimmune and neurological disease. Proceedings from American Academy of Allergy, Asthma and Immunology Symposium, March 20-23, 1997, Tucson, AZ, 95-99.
55. Thomson, A. (1998) The Cytokine Handbook San Diego, CA: Academic Press. 158, 215, 374, 414, 605.
56. Riddlesden, S. J., Lassman, H., Zimprich, F., Morgan, B. P., Linington, C. (1993) The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am. J. Pathol. 143, 555-564.
57. Hart, M. H., and Fabr, Z. (1995) CNS antigen presentation. Trends Neurosci. 18, 475-481.
58. Ransohoff, R. M., Hamilton, T. A., Tani, M., Stoler, M. H., Shick, M. E., Major, J. A., et al. (1993) Astrocyte expression of MRNA encoding cytokines IP-10 and JE.MCP-1 in EAE. FASEB J. 7, 592-600.
59. Merril, J. E., Benveniste, N. (1996) Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 19, 331-338.
60. Liedtke, W., Canella, B., Mazzaccaro, R. J., Clements, J. M., Miller, K. M., Wucherpfenning, K. W., Gearing, A. J. H., Raine, C. S. (1998) Effective treatment of models of multiple sclerosis by matrix mettaloproteinase inhibitors. Ann. Neurol. 44, 35-46.
61. Crockard, A. D., Treacy, M. T., Droogan, A. G., McNeill, T. A., Marokins, S. A. (1995) Transient immunomodulation by intravenous methylprednisolone treatment of multiple sclerosis. Multiple Sclerosis 2, 20-40.
62. Yong, V. W., Chabot, S., Stuve, O., and Williams, G. (1998) Interferon beta in the treatment of multiple sclerosis, mechanism of action. Neurology 51, 682-689.
63. IFN-β Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing remitting multiple sclerosis -I-clinical results of a multicenter, randomized, double blind, placebo controlled trial. Neurology 43, 566-661.
64. Jacobs, L, Cookfair, D., Rudick, R., et al. (1996) Intramuscular interferon beta 1-a for disease progression in relapsing-remitting multiple sclerosis Ann. Neurol. 39, 285-294.
65. Johnson, K. P., Brooks, B. R., Cohen, J. A., Ford, C.C., Goldstein, J., Lasak, R. P., Meyers, L. W., Panitch, H. S., Rose, J. W., Schiffer, R. B., Vollmer, T., Weiner, L. P., Wolinsky, J. S. (1998) Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Neurology 50, 701-718.
66. Fu, L. Matthews, P. M., DeStefano, N., Worsley, K. J., Narayanan, S., Francis, G. S., Antel, J. P., Wolfson, C., Arnold, D. L. (1998) Imaging axonal damage of normal appearing white matter in multiple sclerosis. Brain 121, 103-113.
67. Losseff, N. A., Miller, D. H. (1998) Measures of brain and spinal cord atrophy in multiple sclerosis. J. Neurol. Neurosurg. Psych. 64 (Suppl. 1), S102-S105.
68. Lycke, J. N., Karlsson, J. E., Andersen, O., Rosengren, L. E. (1998) Neurofilament protein in CSF a potential marker of activity in multiple sclerosis. Neurol. Neurosurg. Psych. 64, 402-404.